In this very special podcast, we speak to two people heavily involved in the Norwegian Life Sciences scene - Bjørn Klem (General Manager of the Oslo Cancer Cluster Incubator (OCCI)), and Bjørn Steen Skålhegg (CEO of Arctic Pharma, one of the OCCI members). We discuss how the OCCI supports its members to accelerate the new development of new cancer diagnostics and medicines, and how IP fits in to that process; we also discover how Arctic Pharma has grown and developed from its early start-up days, and how IP has played such an important part in that growth.